Cell surface markers in multiple myeloma (Q40663401)

22 September 2017

1 reference

title

Cell surface markers in multiple myeloma (English)

1 reference

22 September 2017

G J Ruiz-Argüelles

1

1 reference

PubMed ID

8015335

22 September 2017

J F San Miguel

series ordinal

2

1 reference

PubMed ID

8015335

22 September 2017

language of work or name

English

0 references

publication date

1 July 1994

1 reference

22 September 2017

1 reference

22 September 2017

69

1 reference

22 September 2017

7

1 reference

22 September 2017

684-690

1 reference

Analysis of surface antigen expression of human immunoglobulin-secreting cells: phenotypic heterogeneity in normal counterparts of myeloma cells

22 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961350-0

Immunological phenotype of neoplasms involving the B cell in the last step of differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961350-0

A monoclonal antibody reactive with a subset of human plasma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961350-0

Surface expression of human myeloma cells: an analysis using a panel of monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961350-0

Markers of multiple hematopoietic-cell lineages in multiple myeloma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961350-0

Immunophenotypic heterogeneity of multiple myeloma: influence on the biology and clinical course of the disease. Castellano-Leones (Spain) Cooperative Group for the Study of Monoclonal Gammopathies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961350-0

Plasmablastic multiple myeloma: an immunologically different subtype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961350-0

Clinical features of common acute lymphoblastic leukemia antigen (CALLA)-positive myeloma: report of four cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961350-0

CD10-(CALLA)-Positive Lymphocytes in Myeloma: Evidence that they are a Malignant Precursor Population and are of Germinal Centre Origin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961350-0

Biology and treatment of multiple myeloma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961350-0

Multiple myeloma: relationship between light chain isotype suppression, labelling index of plasma cells, and CD38 expression on peripheral blood lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961350-0

Cell surface expression of beta 2-microglobulin (beta 2m) correlates with stages of differentiation in B cell tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961350-0

Peripheral blood B cell labeling indices are a measure of disease activity in patients with monoclonal gammopathies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961350-0

Human myeloma: several subsets of circulating lymphocytes express plasma cell-associated antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961350-0

Adhesion receptors of the immune system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961350-0

Expression of multiple beta 1 integrins on circulating monoclonal B cells in patients with multiple myeloma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961350-0

No detectable malignant B cells in the peripheral blood of patients with multiple myeloma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961350-0

Detection of monoclonal B lymphocytes in bone marrow and peripheral blood of multiple myeloma patients by immunoglobulin gene rearrangement studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961350-0

The mutation of N-ras oncogene does not involve myeloid and erythroid lineages in a case of multiple myeloma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961350-0

Lymphoid subsets and prognostic factors in multiple myeloma. Cooperative Group for the Study of Monoclonal Gammopathies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961350-0

T-cell subpopulations in multiple myeloma: correlation with clinical disease status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961350-0

Increased expression of natural-killer-associated and activation antigens in multiple myeloma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961350-0

Increase in the suppressor-inducer T cell subset in multiple myeloma and monoclonal gammopathy of undetermined significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961350-0

Selective loss of CD4+ CD45R+ T cells in peripheral blood of multiple myeloma patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961350-0

T-cell subpopulations in patients with monoclonal gammopathies: essential monoclonal gammopathy, multiple myeloma, and Waldenstrom macroglobulinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961350-0

T Cells in Monoclonal Gammopathies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961350-0

Abnormal monoclonal antibody-defined helper/suppressor T-cell subpopulations in multiple myeloma: relationship to treatment and clinical stage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961350-0

Strong natural killer (NK) cell activity in bone marrow of myeloma patients: accelerated maturation of bone marrow NK cells and their interaction with other bone marrow cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961350-0

CD5 B lymphocyte antigen in monoclonal gammopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961350-0

Multiple myeloma and chronic lymphocytic leukemia: parallels and contrasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961350-0

10.1016/S0025-6196(12)61350-0

7 January 2021

Identifiers

DOI

1 reference

22 September 2017

1 reference

PubMed ID

8015335